Skip to main content
Erschienen in: Indian Journal of Gastroenterology 5/2017

09.10.2017 | Original Article

Anemia in patients with ulcerative colitis in remission: A study from western India

verfasst von: Alisha Chaubal, Vikas Pandey, Dhaval Choksi, Prateik Poddar, Meghraj Ingle, Aniruddha Phadke, Prabha Sawant

Erschienen in: Indian Journal of Gastroenterology | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Anemia is common in patients with active ulcerative colitis. We aimed to study the anemia profile in patients with ulcerative colitis in clinical remission.

Methods

Sixty-four patients with ulcerative colitis and with a clinical Mayo score less than 3 for at least 3 months were evaluated for anemia. Initial screening was done by hemogram and only patients with anemia were evaluated further for the cause of anemia. We also screened a control population for anemia. Patients with mild anemia were given oral iron, moderate anemia were given intravenous iron and severe anemia were given blood transfusion.

Results

The mean hemoglobin in ulcerative colitis patients was 11.75 g/dL and in controls was 13.1 g/dL (p=0.011). The prevalence of anemia was 53.1% in the ulcerative colitis patients and 13.3% in the controls (p=<0.001). 58.8% had mild anemia, 29.4% had moderate anemia and 8.8% had severe anemia. Iron deficiency was the most common cause of anemia (70.5%) followed by anemia of chronic disease combined with iron deficiency in 23.5%. Ferritin levels did not correlate with hemoglobin levels. Oral iron increased the hemoglobin by 1.4 g/dL and intravenous iron by 2.2 g/dL at 1 month.

Conclusion

Anemia was seen in more than half of patients with ulcerative colitis in clinical remission, iron deficiency being the most common cause.
Literatur
1.
Zurück zum Zitat Bruner AB, Joffe A, Duggan AK, et al. Randomised study of cognitive effects of iron supplementation in non-anemic iron-deficient adolescent girls. Lancet. 1996;348:992–6.CrossRefPubMed Bruner AB, Joffe A, Duggan AK, et al. Randomised study of cognitive effects of iron supplementation in non-anemic iron-deficient adolescent girls. Lancet. 1996;348:992–6.CrossRefPubMed
2.
Zurück zum Zitat Chavarro JE, Rich-Edwards JW, Rosner BA, et al. Iron intake and risk of ovulatory infertility. Obstet Gynecol. 2006;108:1145–52.CrossRefPubMed Chavarro JE, Rich-Edwards JW, Rosner BA, et al. Iron intake and risk of ovulatory infertility. Obstet Gynecol. 2006;108:1145–52.CrossRefPubMed
4.
Zurück zum Zitat Evstatiev R, Marteau P, Iqbal T, et al. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology. 2011;141:846–53. e841–42CrossRefPubMed Evstatiev R, Marteau P, Iqbal T, et al. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology. 2011;141:846–53. e841–42CrossRefPubMed
5.
Zurück zum Zitat Gisbert JP, Gomollon F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol. 2008;103:1299–307.CrossRefPubMed Gisbert JP, Gomollon F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol. 2008;103:1299–307.CrossRefPubMed
6.
Zurück zum Zitat Khan N, Patel D, Shah Y, et al. Factors predicting testing and treatment of iron deficiency in a nationwide cohort of anemic UC patients. Inflamm Bowel Dis. 2016;22:2894–901.CrossRefPubMed Khan N, Patel D, Shah Y, et al. Factors predicting testing and treatment of iron deficiency in a nationwide cohort of anemic UC patients. Inflamm Bowel Dis. 2016;22:2894–901.CrossRefPubMed
7.
Zurück zum Zitat Stein J, Hartmann F, Dignass AU. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol. 2010;7:599–610.CrossRefPubMed Stein J, Hartmann F, Dignass AU. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol. 2010;7:599–610.CrossRefPubMed
8.
Zurück zum Zitat Oustamanolakis P, Koutroubakis IE, Kouroumalis EA. Diagnosing anemia in inflammatory bowel disease: beyond the established markers. J Crohns Colitis. 2011;5:381–91.CrossRefPubMed Oustamanolakis P, Koutroubakis IE, Kouroumalis EA. Diagnosing anemia in inflammatory bowel disease: beyond the established markers. J Crohns Colitis. 2011;5:381–91.CrossRefPubMed
9.
Zurück zum Zitat Skikne BS, Punnonen K, Caldron PH, et al. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index. Am J Hematol. 2011;86:923–7.CrossRefPubMed Skikne BS, Punnonen K, Caldron PH, et al. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index. Am J Hematol. 2011;86:923–7.CrossRefPubMed
10.
Zurück zum Zitat Dignass AU, Gasche C, Bettenworth D, et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2015;9:211–22.CrossRefPubMed Dignass AU, Gasche C, Bettenworth D, et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2015;9:211–22.CrossRefPubMed
11.
Zurück zum Zitat Lucendo AJ, Arias Á, Roncero Ó, et al. Anemia at the time of diagnosis of inflammatory bowel disease: Prevalence and associated factors in adolescent and adult patients. Dig Liver Dis. 2016;49:405-411. Lucendo AJ, Arias Á, Roncero Ó, et al. Anemia at the time of diagnosis of inflammatory bowel disease: Prevalence and associated factors in adolescent and adult patients. Dig Liver Dis. 2016;49:405-411.
12.
Zurück zum Zitat Gasche C, Waldhoer T, Feichtenschlager T, et al. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. Am J Gastroenterol. 2001;96:2382–7.PubMed Gasche C, Waldhoer T, Feichtenschlager T, et al. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. Am J Gastroenterol. 2001;96:2382–7.PubMed
13.
Zurück zum Zitat Onken JE, Bregman DB, Harrington RA, et al. A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Transfusion. 2014;54:306–15.PubMed Onken JE, Bregman DB, Harrington RA, et al. A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Transfusion. 2014;54:306–15.PubMed
14.
Zurück zum Zitat Ford D, Cohen M, Strauss W, et al. Evaluation of ferumoxytol treatment for iron deficiency anemia in patients with gastrointestinal disorders who have a history of unsatisfactory oral iron therapy: results of a phase III, randomized, placebo-controlled trial. Gastroenterology. 2013;144:S754.CrossRef Ford D, Cohen M, Strauss W, et al. Evaluation of ferumoxytol treatment for iron deficiency anemia in patients with gastrointestinal disorders who have a history of unsatisfactory oral iron therapy: results of a phase III, randomized, placebo-controlled trial. Gastroenterology. 2013;144:S754.CrossRef
Metadaten
Titel
Anemia in patients with ulcerative colitis in remission: A study from western India
verfasst von
Alisha Chaubal
Vikas Pandey
Dhaval Choksi
Prateik Poddar
Meghraj Ingle
Aniruddha Phadke
Prabha Sawant
Publikationsdatum
09.10.2017
Verlag
Springer India
Erschienen in
Indian Journal of Gastroenterology / Ausgabe 5/2017
Print ISSN: 0254-8860
Elektronische ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-017-0791-z

Weitere Artikel der Ausgabe 5/2017

Indian Journal of Gastroenterology 5/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.